JP MORGAN/PUT/CORTEVA/45/0.1/21.06.24 Share Price

Warrant

DE000JL7PD61

Delayed Börse Stuttgart 15:09:54 14/06/2024 BST
0.001 EUR 0.00% Intraday chart for JP MORGAN/PUT/CORTEVA/45/0.1/21.06.24
Current month-83.33%
1 month-96.15%
Date Price Change
14/06/24 0.001 0.00%
13/06/24 0.001 -50.00%
12/06/24 0.002 -50.00%
11/06/24 0.004 -33.33%
10/06/24 0.006 +100.00%

Delayed Quote Börse Stuttgart

Last update June 14, 2024 at 03:09 pm

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying CORTEVA, INC.
Issuer J.P. Morgan
WKN JL7PD6
ISINDE000JL7PD61
Date issued 13/07/2023
Strike 45 $
Maturity 21/06/2024 (5 Days)
Parity 10 : 1
Emission price 0.19
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 0.57
Lowest since issue 0.001
Delta-0.08x
Omega 22.96
Premium12.41x
Gearing298.86x
Moneyness 0.8792
Difference Strike -6.18 $
Difference Strike %-13.73%
Spread 0.03
Spread %96.77%
Theoretical value 0.0160
Implied Volatility 67.76 %
Total Loss Probability 90.92 %
Intrinsic value 0.000000
Present value 0.0160
Break even 44.83 €
Theta-0.02x
Vega0x
Rho-0x

Company Profile

Corteva, Inc. specializes in the manufacturing and marketing of agricultural and phytosanitary products. Net sales break down by activity as follows: - production of seed and grain (51.4%): mainly corn seeds (66.2% of net sales) and soybeans (20.2%); - manufacture of crop protection products (48.6%): herbicides (54.2% of net sales), insecticides (21.6%), fungicides (17.1%) and other 7.1%). At the end of 2022, the group had 85 production sites worldwide. Net sales are distributed geographically as follows: the United States and Canada (47.5%), Latin America (25.5%), Europe/Middle East/Africa (18.6%), and Asia/Pacific (8.4%).
Sector
-
More about the company

Ratings for Corteva, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Corteva, Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
21
Last Close Price
51.18 USD
Average target price
63.65 USD
Spread / Average Target
+24.36%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW